These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7371334)

  • 1. Functional asplenia in Sezary syndrome.
    Balachandran S; Kumar R; Kuo TT
    Clin Nucl Med; 1980 Apr; 5(4):149-51. PubMed ID: 7371334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-111 leukocyte scanning and partial functional asplenia in a patient with Sézary syndrome.
    Hazenberg HJ; Hiddink HJ; Link EA; Muller CJ; Smeenk G; Brouwers TM
    Clin Nucl Med; 1983 Jan; 8(1):3-6. PubMed ID: 6831816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic imaging in the initial staging of mycosis fungoides and Sézary syndrome.
    Kulin PA; Marglin SI; Shuman WP; Chew DE; Olerud JE
    Arch Dermatol; 1990 Jul; 126(7):914-8. PubMed ID: 2360839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sézary syndrome: a model for migration of T lymphocytes to skin.
    Miller RA; Coleman CN; Fawcett HD; Hoppe RT; McDougall IR
    N Engl J Med; 1980 Jul; 303(2):89-92. PubMed ID: 6966761
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversible functional asplenia in chronic aggressive hepatitis.
    Dhawan VM; Spencer RP; Sziklas JJ
    J Nucl Med; 1979 Jan; 20(1):34-6. PubMed ID: 430176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of Sezary syndrome with somatostatin receptor scintigraphy.
    Heule F; Vanhagen PM; van Dongen JJ; Krenning EP; Reubi JC; van Joost T
    Br J Dermatol; 1996 Jan; 134(1):178-9. PubMed ID: 8745911
    [No Abstract]   [Full Text] [Related]  

  • 7. Sézary syndrome: infiltration of the gastric wall--does it matter?
    Schuler MK; Kroschinsky F; Schaich M; Kalauch A; Stroszczynski C; Kellermann S; Ehninger G; Benter T
    Ann Hematol; 2012 Sep; 91(9):1507-9. PubMed ID: 22362119
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of T-cell lymphoma by radiolabelled monoclonal antibody.
    Bunn PA; Carrasquillo JA; Keenan AM; Schroff RW; Foon KA; Hsu SM; Gazdar AF; Reynolds JC; Perentesis P; Larson SM
    Lancet; 1984 Nov; 2(8413):1219-21. PubMed ID: 6150269
    [No Abstract]   [Full Text] [Related]  

  • 9. Splenic imaging in a patient with functional asplenia.
    Wagman PG; Dworkin HJ
    Clin Nucl Med; 1989 Apr; 14(4):264-7. PubMed ID: 2706868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated positron-emission tomography and computed tomography manifestations of cutaneous T-cell lymphoma.
    Kamstrup MR; Gniadecki R; Friberg L
    Arch Dermatol; 2012 Dec; 148(12):1420-2. PubMed ID: 23247490
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased splenic perfusion without functional asplenia.
    Spencer RP; Sziklas JJ; Suresh K
    Clin Nucl Med; 1979 May; 4(5):191-3. PubMed ID: 455859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
    Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
    Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sezary syndrome presenting with tumourous involvement of the breast detected by (18) F-fluorodeoxyglucose positron-emission tomography/computed tomography.
    Tadmor T; Attias D; Polliack A
    Br J Haematol; 2012 Aug; 158(4):432. PubMed ID: 22765262
    [No Abstract]   [Full Text] [Related]  

  • 15. The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma.
    Sato M; Ishikawa O; Miyachi Y
    Br J Dermatol; 1995 Nov; 133(5):810-3. PubMed ID: 8555042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast: Sezary Syndrome: A Unique Presentation.
    Bedayat A; Mirzabeigi M; Yu H; Hultman R; MacMaster S
    Breast J; 2015; 21(4):423-7. PubMed ID: 25939954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional asplenia in childhood onset systemic lupus erythematosus.
    Malleson P; Petty RE; Nadel H; Dimmick JE
    J Rheumatol; 1988 Nov; 15(11):1648-52. PubMed ID: 3070028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab.
    Kho B; Wong HHN; Sin CF; Leung RYY; Kwong YL
    Ann Hematol; 2017 Dec; 96(12):2121-2123. PubMed ID: 28828693
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional asplenia in immunoblastic lymphoma.
    Gross DJ; Braverman AJ; Koren G; Rabinowitz YS; Gordon R; Okon E
    Arch Intern Med; 1982 Nov; 142(12):2213-5. PubMed ID: 6897164
    [No Abstract]   [Full Text] [Related]  

  • 20. Sézary syndrome in a Malay--case report and literature review.
    Yuen P; Chan HL; Lee YS
    Singapore Med J; 2001 May; 42(5):224-7. PubMed ID: 11513062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.